Are Drug Companies Ripping Us Off?

Pharmaceutical formularies, like other medical solutions, are best priced according to the value they deliver relative to the alternative treatment for the target disease. If the new solution provides more value, it should have a proportionately higher price. If it provides less value, it should have a proportionately lower price. This is the concept behind value-based price: price to reflect the prices of alternatives adjusted for their differential value for the target customer.

Read More

Designing a Product Roadmap-II

It is not expected that all the dates mentioned in the product roadmaps are hard deadlines. An audience is cognizant of the fact that sometimes product launches can get delayed due to unforeseen reasons. Yet consistently not sticking to the roadmap may lead the audience to question a firm’s credibility. A great idea would be to backdate the roadmap, to some extent, to demonstrate the compliance so far and then to open up the future.

Read More

Maintaining Pricing Excellence During Currency Depreciation

It is preferable to maintain or carefully increase prices in a clear, methodical way, only decreasing cost slowly and with much consideration. Careful analysis is required to take into account different SKUs, product lines, geographies, and customer segments, adjusting prices in the way that fits best each unique category.

Read More

Trends in Automobiles and Auto Show Practices Seen at the Chicago Auto Show

I have noticed one car company breaking the rules of engagement at the Chicago Auto Show the past two years. Kia Motors America, Inc. has public relations people on hand like every car company at the show. They also had product mangement exectutives like Vice President, Product Planning Orth Hedrick and Manager, Long Range Strategy Steve Kosowski onsite. They stayed onsite for both press days – interacting with people and taking product feedback.

Read More